New Alzheimer's drug: How much of a breakthrough is it?
November 30, 2022
22 min
Full
44 of 1,000

November 30, 2022
New Alzheimer's drug: How much of a breakthrough is it?
0:00 / 22:02
Excerpt playback isn’t available for this episode — use the full-episode link.
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Sky News Episodes Around November 30, 2022
Episode 44 of 1,000 — walk the feed in the order it was published.
22:02This episodeNew Alzheimer's drug: How much of a breakthrough is it?
Summary
A drug used in clinical trials has been found to slow memory loss in patients with the condition - and although lecanemab is not a cure, it has got a lot of scientists and others very excited. <br /><br />On the Sky News Daily podcast, Niall Paterson speaks to Scott Mitchell, the widower of the late Dame Barbara Windsor, who died with the disease, about what the breakthrough means to his campaign to raise awareness. <br /><br />Plus Tom Clarke, Sky’s science and technology editor, explores how much of a difference the drug could make and what happens next. <br /><br />Senior podcast producer: Annie Joyce <br />Interviews producer: Alys Bowen <br />Podcast promotions producer: David Chipakupaku <br />Archiver researcher: Nelly Stefanova <br />Editor: Philly Beaumont
Episode details and artwork are published by the show’s own feed. Sentinel plays short cited excerpts and links every episode back to its publisher.





























